Capital Performance Advisors »

Theravance Biopharma shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $40 5 8.00

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Specialized Funds Div App Etf (VIG)
NVIDIA Corporation (NVDA)

View all positions for Capital Performance Advisors

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
State Street Corporation
Oasis Management
Camber Capital Management
Geode Capital Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Dimensional Fund Advisors
Nuveen Asset Management

View all funds holding Theravance Biopharma